WallStreetZenWallStreetZen

NASDAQ: ATHA
Athira Pharma Inc Stock Ownership - Who owns Athira Pharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Athira Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Martin Javier SanCHIEF MEDICAL OFFICER2025-07-0110,842$0.29
$3.18kSell
Robert RenningerSVP Finance and Accounting2025-07-012,897$0.29
$848.82Sell
Kevin ChurchCHIEF SCIENTIFIC OFFICER2025-07-018,526$0.29
$2.50kSell
Mark WorthingtonGeneral Counsel and CCO2025-07-018,526$0.29
$2.50kSell
Mark James LittonPresident and CEO2025-07-0125,123$0.29
$7.36kSell
Robert RenningerSVP Finance and Accounting2025-05-1910,000$0.23
$2.31kBuy
Kevin ChurchCHIEF SCIENTIFIC OFFICER2025-05-1910,000$0.23
$2.31kBuy
Kevin ChurchCHIEF SCIENTIFIC OFFICER2025-01-028,510$0.56
$4.78kSell
Martin Javier SanCHIEF MEDICAL OFFICER2025-01-0210,826$0.56
$6.08kSell
Robert RenningerVP of Finance2025-01-022,881$0.56
$1.62kSell

1 of 2

ATHA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ATHA insiders and whales buy or sell their stock.

ATHA Shareholders

What type of owners hold Athira Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC137.00%5,402,964$20.80MInsider
Joseph Edelman78.98%3,114,805$11.99MInsider
Rtw Investments LP67.67%2,668,913$10.28MInsider
Perceptive Advisors LLC13.70%540,296$2.08MInstitution
Mark James Litton8.76%345,491$1.33MInsider
Bml Capital Management LLC8.19%323,066$1.24MInstitution
Kevin Church4.28%168,901$650.27kInsider
Glenna Mileson4.06%159,930$615.73kInsider
John M. Fluke Jr.3.94%155,346$598.08kInsider
Vanguard Group Inc3.90%153,789$592.09kInstitution

1 of 3

ATHA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ATHA11.96%88.04%Net Selling
SNGX1.31%98.69%Net BuyingNet Buying
CRIS7.47%92.53%
KAPA2.14%35.55%
PULM4.84%95.16%
View Top Biotech Stocks

Athira Pharma Stock Ownership FAQ

Who owns Athira Pharma?

Athira Pharma (NASDAQ: ATHA) is owned by 43.52% institutional shareholders, 320.25% Athira Pharma insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Athira Pharma shareholder, owning 5.40M shares representing 137.00% of the company. Perceptive Advisors LLC's Athira Pharma shares are currently valued at $20.96M.

If you're new to stock investing, here's how to buy Athira Pharma stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.